APA (7th ed.) Citation

Rubio-Terrés, C., Codes, R. G. d., Rubio-Rodríguez, D., Evers, T., & Cerrato, S. G. Cost-effectiveness Analysis of Rivaroxaban versus Acenocoumarol in the Prevention of Stroke in Patients with Non-valvular Atrial Fibrillation in Spain. Columbia Data Analytics, LLC.

Chicago Style (17th ed.) Citation

Rubio-Terrés, Carlos, Ruth Graefenhain de Codes, Darío Rubio-Rodríguez, Thomas Evers, and Santiago Grau Cerrato. Cost-effectiveness Analysis of Rivaroxaban Versus Acenocoumarol in the Prevention of Stroke in Patients with Non-valvular Atrial Fibrillation in Spain. Columbia Data Analytics, LLC.

MLA (9th ed.) Citation

Rubio-Terrés, Carlos, et al. Cost-effectiveness Analysis of Rivaroxaban Versus Acenocoumarol in the Prevention of Stroke in Patients with Non-valvular Atrial Fibrillation in Spain. Columbia Data Analytics, LLC.